ReWalk Robotics Stock (NASDAQ:LFWD)


ForecastRevenueFinancialsChartTranscripts

Previous Close

$1.42

52W Range

$1.22 - $5.28

50D Avg

$1.66

200D Avg

$2.45

Market Cap

$14.78M

Avg Vol (3M)

$2.44M

Beta

1.51

Div Yield

-

LFWD Company Profile


ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

80

IPO Date

Sep 12, 2014

Website

LFWD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Product$19.92M

Fiscal year ends in Dec 24 | Currency in USD

LFWD Financial Summary


Dec 24Dec 23Dec 22
Revenue$25.66M$13.85M$5.51M
Operating Income$-19.55M$-23.61M$-19.10M
Net Income$448.00K$-22.13M$-19.57M
EBITDA$-19.55M$-21.77M$-18.90M
Basic EPS$0.01$-2.59$-2.20
Diluted EPS$0.01$-2.59$-2.20

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Mar 07, 25 | 8:30 AM
Q3 24Nov 12, 24 | 8:30 AM
Q2 24Aug 15, 24 | 8:30 AM